What is the initial Positive End-Expiratory Pressure (PEEP) strategy in patients with severe Chronic Obstructive Pulmonary Disease (COPD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

In severe COPD, the initial PEEP strategy should start with low levels, as high PEEP can exacerbate dynamic hyperinflation and worsen outcomes, with a recommended starting point of around 5 cmH2O or less, as implied by the need to avoid excessive airway pressures and allow for adequate expiratory time 1. When managing severe COPD, it's crucial to consider the patient's underlying pathophysiology, which includes air trapping and hyperinflation.

  • The BTS/ICS guideline for the ventilatory management of acute hypercapnic respiratory failure in adults suggests that in obstructive disease, initial settings should aim for oxygenation with a SaO2 of 88-92%, and acid-base balance with a pH of 7.2-7.4, allowing for permissive hypercapnia if inspiratory airway pressure exceeds 30 cmH2O 1.
  • A key consideration in COPD management is the avoidance of dynamic hyperinflation, which can be exacerbated by high PEEP levels or inadequate expiratory times, as evidenced by the statement that in airflow obstruction, prolonging the expiratory time reduces dynamic hyperinflation (gas-trapping) 1.
  • The initial PEEP setting should be individualized, taking into account the patient's specific condition, including the severity of their COPD, the presence of any comorbidities, and their response to initial ventilatory settings.
  • It's also important to closely monitor the patient's respiratory mechanics, including plateau pressures, driving pressures, and auto-PEEP, and to titrate PEEP carefully based on oxygenation requirements, work of breathing, and hemodynamic stability, as excessive PEEP can lead to barotrauma or hemodynamic compromise.
  • In some cases, permissive hypercapnia may be an acceptable strategy to avoid excessive ventilatory pressures, as long as the pH remains above 7.2, which is a consensus target when pH control is difficult, and is supported by the ARDS literature demonstrating that a pH above 7.2 is well tolerated 1.

From the Research

Initial PEEP Strategy in Severe COPD

  • The initial PEEP strategy in severe COPD is crucial to reduce the workload for ventilation and prevent pulmonary hyperinflation 2.
  • Application of low levels of PEEP can be used to reduce intrinsic positive end-expiratory pressure (PEEPi) and the magnitude of the inspiratory effort during assisted mechanical ventilation or pressure support and weaning 2.
  • The use of PEEP in COPD patients requires close monitoring of the end-expiratory lung volume, which can be accomplished by inspection of flow/volume curves during application of increasing levels of PEEP 2.
  • There is no specific guideline for titration of the PEEP level in COPD patients, and the optimal PEEP strategy may vary depending on the individual patient's condition 2, 3.

PEEP Setting at the Individual Level

  • Setting the optimal PEEP level at the individual level is crucial to provide lung protection and prevent ventilator-induced lung injury 3.
  • The open lung approach requires that every collapsed unit potentially openable is opened and maintained open, and the methods to assess the recruitment are based on imaging or mechanically-driven gas exchange modifications 3.
  • Comparative studies have shown that the only possible approach to measure the amount of collapsed tissue regaining inflation is the CT scan, and higher PEEP is usually more indicated when the recruitability is higher, as occurs with increasing severity 3.

Management of Severe COPD

  • The management of severe COPD involves a combination of pharmacological and non-pharmacological treatments, including inhaled bronchodilators, steroids, and antibiotics, as well as oxygen therapy, high flow nasal cannulae oxygen therapy, non-invasive mechanical ventilation, and pulmonary rehabilitation 4, 5, 6.
  • Long-acting bronchodilators and inhaled corticosteroids have been shown to reduce exacerbation rates in patients with moderate to severe COPD, and domiciliary oxygen therapy has been demonstrated to prolong survival in patients with resting hypoxia 5.

Related Questions

What is the best course of action for a 68-year-old patient with shortness of breath (SOB), a history of chronic obstructive pulmonary disease (COPD) with emphysema, currently taking inhaled corticosteroid (ICS), long-acting beta-agonist (LABA), long-acting muscarinic antagonist (LAMA), and using albuterol and ipratropium nebulizers, with recent leukocytosis and impaired renal function, following two COPD exacerbations in the past month?
What is the most appropriate treatment for a 65-year-old woman with acute exacerbation of Chronic Obstructive Pulmonary Disease (COPD), presenting with hyperthermia, hypertension, tachycardia, tachypnea, hypoxemia, and hypercapnia, on medications budesonide (corticosteroid)-formoterol (long-acting beta-agonist) inhaler and albuterol (short-acting beta-agonist)-ipratropium (anticholinergic)?
What is the management of acute Chronic Obstructive Pulmonary Disease (COPD) exacerbation?
What is the treatment for acute Chronic Obstructive Pulmonary Disease (COPD) exacerbation in the Emergency Department (ED)?
What is the management plan for a 56-year-old Human Immunodeficiency Virus (HIV) positive male with a history of pulmonary Tuberculosis (TB) and Chronic Obstructive Pulmonary Disease (COPD), presenting with an acute exacerbation of COPD, characterized by clubbing, central cyanosis, hypoxemia, respiratory distress, and type 2 respiratory failure?
What is the treatment for Premature Premature Contractions (PPM)?
What are the algorithmic approaches for medical weight loss in patients with obesity?
Can patients with suicidal ideation be forcibly treated for aspirin (acetylsalicylic acid) overdose with nasogastric (NG) tube insertion and endotracheal intubation?
What is the major tumor marker for Hepatocellular Carcinoma (HCC)?
What is the optimal evidence-based management of adult spinal deformity (ASD)?
What are the causes and management of shoulder dislocation (glenohumeral joint dislocation) in pediatric patients?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.